Influence of cholesterol level on long-term survival and cardiac events after surgical coronary revascularization.

CABG CABG, coronary artery bypass graft HDL-C, high-density lipoprotein cholesterol LDL LDL-C, low-density lipoprotein cholesterol ROC, receiver operating characteristic TC, total cholesterol TC/HDL-C, total cholesterol-to-high-density lipoprotein cholesterol ratio TG, triglycerides dyslipidemia non-HDL non–HDL-C, non–high-density lipoprotein cholesterol statin

Journal

JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 18 09 2021
accepted: 17 02 2022
entrez: 25 8 2022
pubmed: 26 8 2022
medline: 26 8 2022
Statut: epublish

Résumé

Statins have been shown to delay the inevitable progression of atherosclerosis in native coronaries and saphenous vein grafts, thereby reducing ischemic events after surgical coronary revascularization. However, there is significant controversy as to whether titrating statin therapy to concrete cholesterol targets is appropriate. A single-center retrospective analysis of 309 consecutive patients who underwent isolated coronary artery bypass graft in 2007 and 2008 was performed. Measurements of lipid profile subcomponents, namely total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides, in mmol/L, were obtained by retrospective review of electronic health records. The primary end point was cardiac death. The secondary end point was the composite of cardiac events, including cardiac death, nonfatal myocardial infarction, hospitalization for unstable angina, and target lesion revascularization. Database lock date was August 15, 2020. The median follow-up duration was 12.5 years. Cardiac death occurred in 6.8% of the cohort. Cardiac events occurred in 21.7% of the cohort. New-onset myocardial infarction occurred in 8.7% (n = 27), of which 48.1% (n = 13) underwent repeat revascularization. A 2-level nested Cox proportional hazards regression model was constructed to determine whether cholesterol target attainment was independently associated with cardiac events. After risk adjustment, LDL-C, non-HDL-C, total cholesterol (TC), and TC/HDL-C ratio were independently associated with cardiac death. In receiver operating characteristics analyses, the optimal cut-off values for non-HDL-C, LDL-C, and TC/HDL-C ratio were 3.2 mmol/L, 2.3 mmol/L, and 3.5, respectively. Exposure to elevated LDL-C and non-HDL-C cholesterol levels independently predicted long-term cardiac death after coronary artery bypass graft.

Identifiants

pubmed: 36004261
doi: 10.1016/j.xjon.2022.02.022
pii: S2666-2736(22)00086-9
pmc: PMC9390627
doi:

Types de publication

Journal Article

Langues

eng

Pagination

195-203

Informations de copyright

© 2022 The Author(s).

Références

Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
J Am Coll Cardiol. 1995 Jan;25(1):193-7
pubmed: 7798501
Arch Intern Med. 2001 Dec 10-24;161(22):2685-92
pubmed: 11732933
Can J Cardiol. 2010 Nov;26(9):e330-5
pubmed: 21076724
Eur J Cardiothorac Surg. 2014 Feb;45(2):323-8
pubmed: 23671205
N Engl J Med. 1984 Nov 22;311(21):1329-32
pubmed: 6333635
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):337-45
pubmed: 21487090
Circulation. 1998 Mar 10;97(9):916-31
pubmed: 9521341
Circulation. 2000 Jul 11;102(2):157-65
pubmed: 10889125
Circulation. 2008 Oct 28;118(18):1785-92
pubmed: 18852363
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934
pubmed: 24239923
Heart. 2002 Dec;88(6):643-4
pubmed: 12433905
Eur Heart J. 2011 Jul;32(14):1769-818
pubmed: 21712404
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Can J Cardiol. 2021 Aug;37(8):1129-1150
pubmed: 33781847
J Am Coll Cardiol. 2008 May 20;51(20):1938-43
pubmed: 18482661
Am J Cardiol. 1998 Feb 26;81(4A):18B-25B
pubmed: 9526809

Auteurs

Kevin Lim (K)

Division of Cardiothoracic Surgery, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong.

Chris Ho Ming Wong (CHM)

Division of Cardiothoracic Surgery, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong.

Angel Lok Yiu Lee (ALY)

Division of Cardiothoracic Surgery, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong.

Takuya Fujikawa (T)

Division of Cardiothoracic Surgery, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong.

Randolph Hung Leung Wong (RHL)

Division of Cardiothoracic Surgery, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong.

Classifications MeSH